What is Tamm‑Horsfall protein (uromodulin), its normal function, and its clinical relevance in kidney disease, hyperuricemia, and kidney stone formation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tamm-Horsfall Protein (Uromodulin): Structure, Function, and Clinical Significance

Tamm-Horsfall protein (uromodulin) is a kidney-specific glycoprotein uniquely produced by thick ascending limb cells that exists in two distinct forms—a polymerizing urinary form and a non-polymerizing circulating form—with critical roles in kidney homeostasis, protection against stones and infections, and as a key player in both rare genetic kidney diseases and common chronic kidney disease. 1

Origin and Production

  • Uromodulin is exclusively synthesized by tubular cells of the thick ascending limb (TAL) of the loop of Henle and early distal convoluted tubules (DCT), making it the only protein uniquely produced by the kidney. 1

  • It is the most abundant protein in normal urine under physiological conditions, with urinary levels reflecting the kidney's capacity to produce this protein. 1, 2

  • The protein was first discovered in 1950 by Drs. Igor Tamm and Frank Horsfall Jr. as an inhibitor of viral hemagglutination, then rediscovered in 1985 as an immunomodulatory protein. 1

Two Distinct Forms with Different Functions

Polymerizing Form (Urinary)

  • A highly polymerizing form is apically secreted into urine where it generates organized filaments. 1
  • This form undergoes proteolytic cleavage that removes a polymerization-inhibitory pro-peptide, allowing filament formation. 1

Non-Polymerizing Form (Circulating)

  • A non-polymerizing form retains the polymerization-inhibitory pro-peptide and is released basolaterally into the renal interstitium and circulation. 1
  • Serum concentrations are approximately 1000 times lower than urinary levels and are undetectable in anephric patients, confirming exclusive kidney origin. 1
  • These two forms are independently regulated through distinct cellular pathways, representing a more complex biology than previously understood. 1

Normal Physiological Functions

Renal Homeostasis

  • Uromodulin regulates salt reabsorption and cation homeostasis in the thick ascending limb. 1
  • It modulates water and electrolyte balance. 2

Protection Against Urinary Tract Infections

  • Knockout mouse studies demonstrate a protective role against urinary tract infections by preventing bacterial adhesion to uroepithelial cells. 2, 3

Prevention of Kidney Stone Formation

  • Uromodulin protects against renal stone formation through mechanisms involving calcium crystal aggregation inhibition. 2, 3

Immunomodulation

  • The protein has immunomodulatory properties and regulates both renal and systemic oxidative stress. 1
  • It plays a role in kidney innate immunity. 2

Clinical Relevance in Kidney Disease

Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD-UMOD)

  • Missense mutations in the UMOD gene cause ADTKD-UMOD, characterized by progressive kidney disease with interstitial fibrosis, tubular atrophy, and lack of significant glomerular pathology. 1

  • Key clinical features include:

    • Progressive chronic kidney disease leading to end-stage renal disease
    • Hyperuricemia and gout (frequently associated)
    • Impaired urinary concentrating ability
    • Renal cysts
    • Unremarkable urine sediment
    • Autosomal dominant inheritance pattern 4
  • The disease can present in childhood and even infancy, not just adulthood as previously thought. 4

  • Pathogenesis involves intracellular accumulation of mutant uromodulin as the key primary event, with failure of mutant protein to be incorporated into the apical cilium, placing ADTKD in the category of ciliopathies. 4

Chronic Kidney Disease (CKD)

  • Genome-wide association studies identify common UMOD gene polymorphisms as strongly associated with CKD risk in the general population. 2, 3

  • Many single nucleotide polymorphisms (SNPs) around the UMOD gene are associated with kidney disease, suggesting uromodulin plays a modulatory role in CKD progression. 1, 4

  • Urinary uromodulin levels may serve as a useful biomarker for CKD development when adjusted for kidney function. 2

Acute Kidney Injury (AKI)

  • Contrary to conventional views of uromodulin as an instigator of injury, knockout mouse data show a protective role in AKI, possibly through downregulating interstitial inflammation. 5

  • The protein's role in AKI represents an emerging area with potential therapeutic implications. 1

Hypertension

  • Common UMOD variants are associated with hypertension risk, with uromodulin playing a role in blood pressure regulation through effects on salt handling. 1, 3

Hyperuricemia Connection

  • ADTKD-UMOD is frequently associated with hyperuricemia and gout, occurring as part of the disease phenotype. 1, 4

  • The mechanism involves altered tubular function in the thick ascending limb, where uromodulin is produced, affecting uric acid handling. 4

  • Hyperuricemia often precedes the development of significant renal impairment in ADTKD-UMOD patients. 4

Kidney Stone Disease

  • Common UMOD variants are associated with increased kidney stone risk in population studies. 3

  • The protective role against stone formation involves inhibition of calcium crystal aggregation and bacterial adhesion, both of which can serve as nidi for stone formation. 2

Clinical Pitfalls and Important Considerations

  • When measuring uromodulin levels, distinguish between urinary and serum measurements, as they reflect different forms and have different clinical implications. 1

  • Urinary uromodulin levels must be adjusted for kidney function to accurately interpret changes in CKD. 5

  • In suspected ADTKD-UMOD, look for the triad of progressive CKD, hyperuricemia/gout, and family history with autosomal dominant pattern, even in younger patients. 4

  • The absence of significant proteinuria or active urine sediment in the setting of progressive CKD should raise suspicion for ADTKD-UMOD. 4

Emerging Therapeutic Potential

  • Modulation of uromodulin levels and function represents a potential novel therapeutic approach for kidney disease, with ongoing research into modified uromodulin for therapeutic applications. 1

  • Understanding the regulation of the two forms of uromodulin may allow targeted interventions to enhance protective functions while minimizing pathological effects. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Uromodulin: old friend with new roles in health and disease.

Pediatric nephrology (Berlin, Germany), 2014

Research

Uromodulin in kidney injury: an instigator, bystander, or protector?

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.